Unique ID issued by UMIN | UMIN000006718 |
---|---|
Receipt number | R000007709 |
Scientific Title | The suppressant action of the surgical stress |
Date of disclosure of the study information | 2011/11/14 |
Last modified on | 2017/02/20 07:23:22 |
The suppressant action of the surgical stress
The suppressant action of the surgical stress
The suppressant action of the surgical stress
The suppressant action of the surgical stress
Japan |
Esophageal cancer, Gasatric cancer, Colorectal cancer, Hepatocellular carcinoma, Colangiocellular carcinoma, Bile duct cancer, pancreatic carcinoma
Gastrointestinal surgery | Hepato-biliary-pancreatic surgery |
Malignancy
NO
Surgery is known to cause oxidative stress, which can cause the failure of various organs. Surgery is also known to cause a type of metastasis called surgical oncotaxis. These complications can be suppressed by controlling oxidative stress. Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) is activated by a variety of stressors. Eicosapentaenoic acid (EPA) is known to inhibit NF-kB activation. It is thought that EPA can suppress cytokine storm, oxidative stress and surgical oncotaxis. Oxidative stress can be measured with Free Radical Elective Evaluator (FREE) which evaluates the oxidant/antioxidant balance. FREE has a variety of tests: 1) the Diacron-reactive oxygen metabolites test (d-ROMs), which uses the capacity of hydroperoxides, and 2) biological antioxidant potential (BAP), which measures the action of the serum antioxidant potential. The aim of this study was to evaluate the oxidant/antioxidant balance before, during and after surgery, and to evaluate the ability of EPA to suppress oxidative stress when administered before surgery.
Efficacy
Exploratory
Explanatory
Not applicable
To evaluate the ability of EPA to suppress oxidative stress when administered before surgery.
To evaluate the oxidant/antioxidant balance before, during and after surgery.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Food |
To administere eicosapentaenoic acid before surgery
20 | years-old | <= |
Not applicable |
Male and Female
(1) Cancer patients
(2) Written informed conscent to recieve this chemotherapy
(3) More than 20 years old
(4) Eastern Cooperative Oncology Groupe (ECOG) performance status of 0-2
(5) Life expectancy mor than 12 weeks
(6) The patients can take food oraly
(1) Infection or inflammatory case
(2) Severe heart disease
(3) Severe complicated case such as ileus, interstitial pneumonia, uncontrolled DM, liver cirrhosis etc
(4) others
100
1st name | |
Middle name | |
Last name | Hisako Kubota |
Kawasaki Medical school
Digestive Surgery
577 Matsushima Kurasiki-city Okayama, Japan
086-462-1111
kubota@med.kawasaki-m.ac.jp
1st name | |
Middle name | |
Last name | Hisako Kubota |
Kawasaki Medical school
Digestive Surgery
577 Matsushima Kurasiki-city Okayama, Japan
086-462-1111
kubota@med.kawasaki-m.ac.jp
Kawasaki Medical school
Kawasaki Medical school
Self funding
Japan
NO
川崎医科大学(岡山県)
2011 | Year | 11 | Month | 14 | Day |
Unpublished
Completed
2011 | Year | 01 | Month | 11 | Day |
2011 | Year | 11 | Month | 01 | Day |
2017 | Year | 12 | Month | 31 | Day |
2017 | Year | 12 | Month | 31 | Day |
2017 | Year | 12 | Month | 31 | Day |
2017 | Year | 12 | Month | 31 | Day |
2011 | Year | 11 | Month | 14 | Day |
2017 | Year | 02 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007709